FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 329:141-142 July 8, 1993 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: In 1989 we reported that clomipramine was superior to desipramine in reducing hair-pulling symptoms in trichotillomania¹. Three of the 13 subjects completing the initial double-blind crossover trial had complete remissions during the five weeks of clomipramine treatment, and 9 had at least a 50 percent reduction in the severity of symptoms. These benefits were maintained for six months. The chronicity of the disorder and reports of relapses after prolonged drug treatment^1,2,3 raised the question of long-term outcome.

Follow-up information was obtained, by in-person interviews at 2 to 3 years and telephone updates at 4.3 ±0.6 years . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Shapiro, J. (2007). Hair Loss in Women. NEJM 357: 1620-1630 [Full Text]  
• Elliott, A. J., Fuqua, R. W. (2002). Acceptability of Treatments for Trichotillomania: Effects of Age and Severity. Behav Modif 26: 378-399 [Abstract]